tiprankstipranks
Apogee Therapeutics (APGE)
NASDAQ:APGE
US Market
APGE
Apogee Therapeutics
RESEARCH TOOLSreports
Want to see APGE full AI Analyst Report?

Apogee Therapeutics (APGE) Income Statement

364 Followers

Apogee Therapeutics Income Statement

Last quarter (Q4 2025), Apogee Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Apogee Therapeutics's net income was $-69.39M. See Apogee Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.42M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 284.18M$ 216.87M$ 93.00M$ 30.73M
Depreciation and Amortization
$ 1.42M$ 189.00K$ 9.02M$ 0.00
EBITDA
$ -284.18M$ -216.68M$ -74.97M$ -39.78M
Operating Income
$ -285.60M$ -216.87M$ -93.00M$ -30.73M
Other Income/Expenses
$ 30.03M$ 34.74M$ 9.02M$ -9.06M
Pretax Income
$ -255.56M$ -182.13M$ -83.98M$ -39.78M
Net Income
$ -255.84M$ -182.15M$ -83.98M$ -39.78M
Per Share Metrics
Basic EPS
$ -4.22$ -3.30$ -1.66$ -0.79
Diluted EPS
$ -4.22$ -3.30$ -1.66$ -0.79
Weighted Average Shares Outstanding
 60.69M 55.19M 50.66M 50.67M
Weighted Average Shares Outstanding (Diluted)
 60.69M 55.19M 50.66M 50.67M
Currency in USD

Apogee Therapeutics Earnings and Revenue History